Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2012
11/01/2012WO2012146259A1 Method for determining clinically relevant hypoxia in cancer
11/01/2012WO2012146251A1 Method for detecting mutations using a three primer system and differently melting amplicons
11/01/2012WO2012145861A1 Methods of nucleic acid liquid-phase extraction and detection
11/01/2012WO2012145794A1 Method of determining response to treatment with immunomodulatory composition
11/01/2012WO2012145786A1 An assay of cell mediated immune responsiveness
11/01/2012WO2012125220A3 Methods for isolation, identification, and quantification of mirnas
11/01/2012WO2012122017A3 Method for rapid identification of drug targets and drug mechanisms of action in human cells
11/01/2012WO2012121746A3 Imaging beta cell mass
11/01/2012WO2012118928A3 Glycoprofiling with multiplexed suspension arrays
11/01/2012WO2012116289A3 Microbial signatures as indicators of radiation exposure
11/01/2012WO2012114312A3 Exogenous internal positive control
11/01/2012WO2012106081A3 Methods for reducing nucleic acid damage
11/01/2012WO2012106072A3 Methods for minimizing sequence specific bias
11/01/2012WO2012102584A9 Sensor for detecting target virus, and method for screening target virus and analyzing mutation location using same
11/01/2012WO2012097319A3 Highly efficient gene-regulatory element screening assay and compositions for performing the same
11/01/2012WO2012097318A3 Modified dna polymerases for improved amplification
11/01/2012WO2012094643A3 Esophageal cytokine expression profiles in eosinophilic esophagitis
11/01/2012WO2012088339A3 Nanopore-based single dna molecule characterization using speed bumps
11/01/2012WO2012080816A3 Single nucleotide polymorphism associated with risk of insulin resistance development
11/01/2012WO2012078793A3 Methods and compositions related to tazarotene-induced gene 1 (tig1)
11/01/2012WO2012054735A3 Systems and methods for assessing biomolecule characteristics
11/01/2012WO2012050365A3 Biomarker for diagnosing glioblastoma or predicting prognosis of glioblastoma patients, and use thereof
11/01/2012WO2012046219A3 Compositions, methods and kits to detect adenovirus nucleic acids
11/01/2012WO2012031008A3 Cancer-related biological materials in microvesicles
11/01/2012WO2012019198A3 Assay systems for genetic analysis
11/01/2012WO2012012803A3 Methods for detection of rare subpopulations of cells and highly purified compositions of cells
11/01/2012WO2012004759A3 Method for identifying a pepsin resistant alpha amylase
11/01/2012US20120278953 Quantitative Trait Loci Associated With Soybean Cyst Nematode Resistance and Uses Thereof
11/01/2012US20120278929 miRNA396 AND GROWTH REGULATING FACTORS FOR CYST NEMATODE TOLERANCE IN PLANTS
11/01/2012US20120278909 Compositions and methods for determining genetic polymorphisms in the tmem216 gene
11/01/2012US20120278908 Method for the diagnosis/prognosis of age-related macular degeneration
11/01/2012US20120277553 Spectrophotometric measurement in color-based biochemical and immunological assays
11/01/2012US20120277288 Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
11/01/2012US20120277287 Modulating the CDC14B-CDH1-PLK1 Axis and Methods for Sensitizing Target Cells to Apoptosis
11/01/2012US20120277286 Compositions and methods for the treatment or prevention of mitochondrial diseases
11/01/2012US20120277282 Polynucleotides for use in medicine
11/01/2012US20120277281 Polynucleotides for medical use
11/01/2012US20120277255 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277211 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype
11/01/2012US20120277180 Cofactors and Methods for Use for Individuals
11/01/2012US20120277166 Conotoxin peptides useful as inhibitors of neuronal amine transporters
11/01/2012US20120277165 Methods of modulating fucosylation of glycoproteins
11/01/2012US20120277153 Treating liver diseases
11/01/2012US20120277121 Kit for detection of microorganism
11/01/2012US20120277119 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
11/01/2012US20120277116 Disease diagnosis according to saccharide binding
11/01/2012US20120277115 Biomarker for successful aging without cognitive decline
11/01/2012US20120277111 MicroRNA Mediated Neuronal Cell Induction
11/01/2012US20120277110 Parp and adjuvant cisplatin-based chemotherapy in non-small-cell lung cancer
11/01/2012US20120277107 Methods and Compositions for Tagging and Identifying Polynucleotides
11/01/2012US20120276582 Disposable cassette and method of use for blood analysis on blood analyzer
11/01/2012US20120276581 Method for preserving cancellous bone samples and preserved cancellous bone tissue
11/01/2012US20120276580 Microorganism concentration process and concentration agent for use therein
11/01/2012US20120276579 Organic compounds
11/01/2012US20120276577 Method for Determining the Susceptibility of a Cell Strain to Drugs
11/01/2012US20120276574 Microfluidic mixer
11/01/2012US20120276573 Nanotube structures, methods of making nanotube structures, and methods of accessing intracellular space
11/01/2012US20120276572 Methods and compositions for identifying and validating modulators of cell fate
11/01/2012US20120276571 Method of analyzing formation and phase transition characteristic of amorphous calcium carbonate
11/01/2012US20120276570 Peptide Antibody Depletion and its Application to Mass Spectrometry Sample Preparation
11/01/2012US20120276569 Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity
11/01/2012US20120276568 Dry test strip and method for measuring creatinine
11/01/2012US20120276567 Talaromyces transformants
11/01/2012US20120276566 Medium for the specific detection of resistant microorganisms
11/01/2012US20120276565 Stabilization of enzymes with stable coenzymes
11/01/2012US20120276563 Method for screening a potential modulator compound of a taste receptor
11/01/2012US20120276552 Serum spla2-iia as diagnosis marker for prostate and lung cancer
11/01/2012US20120276548 Multimer glycosylated nucleic acid binding protein conjugates and uses thereof
11/01/2012US20120276547 Aptamers selected against live s. pyogenes cells
11/01/2012US20120276545 Method for using division arrested cells in screening assays
11/01/2012US20120276544 Microfabricated Crossflow Devices and Methods
11/01/2012US20120276543 Microfabricated Crossflow Devices and Methods
11/01/2012US20120276542 Quantification of a minority nucleic acid species
11/01/2012US20120276541 Microplates, Reaction Modules and Detection Systems
11/01/2012US20120276540 Method and probe set for detecting cancer
11/01/2012US20120276539 Use of metastasis progressor s100a4 transcripts in body fluids of colorectal and gastric cancer patients
11/01/2012US20120276538 Sequence-specific methods for homogeneous, real-time detection of lamp products
11/01/2012US20120276537 Homologous recombination in the oocyte
11/01/2012US20120276536 Hair Shape Susceptibility Gene
11/01/2012US20120276535 Method for the diagnosis of limbal stem cell deficiency
11/01/2012US20120276534 Probe for Detecting Polymorphism in Exon 12 of NPM1 Gene and Use Thereof
11/01/2012US20120276533 Method for Simultaneously Detecting Polymorphisms of Acetaldehyde Dehydrogenase 2 and Alcohol Dehydrogenase 2
11/01/2012US20120276532 Sample processing device for pretreatment and thermal cycling
11/01/2012US20120276531 Genes for prognosis of cancer
11/01/2012US20120276529 Mutated sumo isoforms and uses thereof
11/01/2012US20120276528 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
11/01/2012US20120276526 Method and system for monitoring and recording viral infection process and screening for agents that inhibit virus infection
11/01/2012US20120276525 Method and system for preventing virus-related obesity and obesity related diseases
11/01/2012US20120276524 Genotyping method
11/01/2012US20120276523 Liquid drop diagnostic assays
11/01/2012US20120276522 Methods and Compositions for Determining Virus Susceptibility to Integrase Inhibitors
11/01/2012US20120276521 ORAL FLUID RAPID ASSAY FOR HEPATITIS C VIRUS (HCV) ANTIBODIES USING NON-ANTIBODY LABELING OF lgA MOLECULES RECOGNIZING HCV PEPTIDE EPITOPES
11/01/2012US20120276520 Assay for mutations in stem cells and their derivatives
11/01/2012US20120276147 Ctsp cancer-testis antigens
11/01/2012US20120276145 Extracellular matrix proteins from haemophilus influenzae biofilms: targets for therapeutic or diagnostic use
11/01/2012US20120276122 Methods for diagnosis and treatment of cellular proliferative disorders
11/01/2012US20120276121 Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
11/01/2012US20120276114 Ifn-gamma inhibitors in the treatment of motoneuron diseases
11/01/2012US20120276113 Methods of treating and preventing colitis involving il-13 and nk-t cells
11/01/2012US20120276105 Use of cytokine expression to predict skin inflammation; methods of treatment
1 ... 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 ... 3003